📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $204.83333
- Sector: Healthcare – Medical Instruments & Supplies
💡 The Growth Thesis
Buy Consensus: Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. Analysts project a 5.5% potential upside. Currently trading at a Forward P/E of 12.222157.